• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳铁蛋白治疗妊娠和非妊娠妇女铁缺乏症的疗效与硫酸亚铁的比较。

Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women.

机构信息

Department of Obstetrician and Gynecology, Sapienza University of Rome, Italy.

出版信息

Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):577-87. doi: 10.1177/039463201002300220.

DOI:10.1177/039463201002300220
PMID:20646353
Abstract

Iron homeostasis in pregnancy compensates for increased iron requirements and in women of child-bearing age for iron loss in menses. Oral administration of ferrous sulfate, prescribed to cure iron deficiency (ID) and ID anemia (IDA), often fails to increase hematological parameters and causes adverse effects. Recently, we demonstrated safety and efficacy of bovine lactoferrin (bLf) in pregnant women suffering from ID/IDA. Two clinical trials were conducted on pregnant and non-pregnant women of child-bearing age suffering from ID/IDA. In both trials, women received oral administration of bLf 100 mg/twice/day (Arm A), or ferrous sulfate 520 mg/day (Arm B). Hematological parameters, serum IL-6 and prohepcidin were assayed before and after therapy. Unlike ferrous sulfate, bLf increased hematological parameters (P less than 0.0001). In pregnant women, bLf decreased serum IL-6 (P less than 0.0001), and increased prohepcidin (P=0.0007). In non-pregnant women bLf did not change the low IL-6 levels while it increased prohepcidin (P less than 0.0001). Ferrous sulfate increased IL-6 (P less than 0.0001) and decreased prohepcidin (P=0.093). bLf established iron homeostasis by modulating serum IL-6 and prohepcidin synthesis, whereas ferrous sulfate increased IL-6 and failed to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA.

摘要

铁在妊娠期间的体内平衡可补偿铁需求的增加,在育龄妇女中可补偿月经导致的铁丢失。硫酸亚铁用于治疗缺铁(ID)和缺铁性贫血(IDA),但常因无法增加血液学参数而导致不良反应。最近,我们证明了牛乳铁蛋白(bLf)在患有 ID/IDA 的孕妇中的安全性和疗效。进行了两项临床试验,一项针对患有 ID/IDA 的孕妇,另一项针对育龄期非孕妇。在两项试验中,女性均接受 bLf(100mg/次,每日两次,A 组)或硫酸亚铁(520mg/日,B 组)口服治疗。治疗前后测定血液学参数、血清 IL-6 和前铁调素。与硫酸亚铁不同,bLf 可增加血液学参数(P 小于 0.0001)。在孕妇中,bLf 降低血清 IL-6(P 小于 0.0001),并增加前铁调素(P=0.0007)。在非孕妇中,bLf 并未改变低水平的 IL-6,但增加了前铁调素(P 小于 0.0001)。硫酸亚铁增加了 IL-6(P 小于 0.0001)并降低了前铁调素(P=0.093)。bLf 通过调节血清 IL-6 和前铁调素合成来建立铁体内平衡,而硫酸亚铁增加了 IL-6,且无法增加血液学参数和前铁调素。bLf 是治疗 ID 和 IDA 比硫酸亚铁更有效和更安全的替代药物。

相似文献

1
Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women.乳铁蛋白治疗妊娠和非妊娠妇女铁缺乏症的疗效与硫酸亚铁的比较。
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):577-87. doi: 10.1177/039463201002300220.
2
Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women.乳铁蛋白治疗孕妇缺铁和缺铁性贫血的疗效与硫酸亚铁的比较。
Biometals. 2010 Jun;23(3):411-7. doi: 10.1007/s10534-010-9335-z. Epub 2010 Apr 21.
3
Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an interventional study.乳铁蛋白与硫酸亚铁治疗遗传性血栓形成倾向孕妇缺铁及缺铁性贫血的安全性和有效性:一项干预性研究。
Biometals. 2014 Oct;27(5):999-1006. doi: 10.1007/s10534-014-9723-x. Epub 2014 Mar 4.
4
Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.乳铁蛋白口服治疗孕妇和非孕妇贫血和炎症性贫血的疗效:一项干预性研究。
Front Immunol. 2018 Sep 21;9:2123. doi: 10.3389/fimmu.2018.02123. eCollection 2018.
5
Lactoferrin or ferrous salts for iron deficiency anemia in pregnancy: A meta-analysis of randomized trials.乳铁蛋白或亚铁盐用于治疗妊娠期缺铁性贫血:随机试验的荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2017 Dec;219:45-52. doi: 10.1016/j.ejogrb.2017.10.003. Epub 2017 Oct 4.
6
Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study.口服牛乳铁蛋白与硫酸亚铁治疗缺铁性贫血孕妇的疗效及耐受性比较:一项前瞻性对照随机研究。
Acta Obstet Gynecol Scand. 2009;88(9):1031-5. doi: 10.1080/00016340903117994.
7
Lactoferrin versus ferrous sulphate for the treatment of iron deficiency anemia during pregnancy: a randomized clinical trial.乳铁蛋白与硫酸亚铁治疗孕期缺铁性贫血的随机临床试验
J Matern Fetal Neonatal Med. 2016;29(9):1387-90. doi: 10.3109/14767058.2015.1049149. Epub 2015 Jun 3.
8
Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.乳铁蛋白治疗炎症性肠病儿童缺铁性贫血的临床试验
Pediatr Res. 2022 Sep;92(3):762-766. doi: 10.1038/s41390-022-02136-2. Epub 2022 Jun 9.
9
Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.口服聚麦芽糖铁复合物与硫酸亚铁治疗缺铁性贫血孕妇的疗效和安全性:一项多中心、随机、对照研究。
J Matern Fetal Neonatal Med. 2011 Nov;24(11):1347-52. doi: 10.3109/14767058.2011.599080. Epub 2011 Aug 23.
10
The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia.口服乳铁蛋白对缺铁及缺铁性贫血孕妇全身铁稳态的影响。
Biochimie. 2009 Jan;91(1):44-51. doi: 10.1016/j.biochi.2008.06.004. Epub 2008 Jun 14.

引用本文的文献

1
The Multifaceted Functions of Lactoferrin in Antimicrobial Defense and Inflammation.乳铁蛋白在抗菌防御和炎症中的多方面功能
Biomolecules. 2025 Aug 16;15(8):1174. doi: 10.3390/biom15081174.
2
Role of lactoferrin and its derived peptides in metabolic syndrome treatment.乳铁蛋白及其衍生肽在代谢综合征治疗中的作用。
Front Endocrinol (Lausanne). 2025 Apr 17;16:1562653. doi: 10.3389/fendo.2025.1562653. eCollection 2025.
3
Effectiveness of Lactoferrin in the Treatment of Anemia in Chronic Kidney Disease: A Single-Center Pilot Study.
乳铁蛋白治疗慢性肾脏病贫血的有效性:一项单中心试点研究。
Indian J Nephrol. 2024 May-Jun;34(3):222-227. doi: 10.4103/ijn.ijn_13_23. Epub 2023 Oct 23.
4
The effectiveness of oral bovine lactoferrin compared to iron supplementation in patients with a low hemoglobin profile: A systematic review and meta-analysis of randomized clinical trials.与铁补充剂相比,口服牛乳铁蛋白对血红蛋白水平低的患者的有效性:一项随机临床试验的系统评价和荟萃分析。
BMC Nutr. 2024 Jan 30;10(1):20. doi: 10.1186/s40795-023-00818-6.
5
Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases.唾液作为口腔及慢性退行性非传染性疾病的生物标志物
Metabolites. 2023 Jul 27;13(8):889. doi: 10.3390/metabo13080889.
6
Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense.杀灭时间与愈合时间:乳铁蛋白和乳铁素在宿主防御中的多方面作用
Pharmaceutics. 2023 Mar 24;15(4):1056. doi: 10.3390/pharmaceutics15041056.
7
Clinical research review: usefulness of bovine lactoferrin in child health.临床研究综述:牛乳铁蛋白在儿童健康中的应用价值。
Biometals. 2023 Jun;36(3):473-489. doi: 10.1007/s10534-022-00430-4. Epub 2022 Aug 9.
8
An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.乳铁蛋白的体外和体内抗病毒活性概述:其抗 SARS-CoV-2 感染的功效。
Biometals. 2023 Jun;36(3):417-436. doi: 10.1007/s10534-022-00427-z. Epub 2022 Aug 3.
9
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.乳铁蛋白作为阿尔茨海默病患者感染 SARS-CoV-2 的免疫增强策略。
Front Immunol. 2022 Apr 25;13:878201. doi: 10.3389/fimmu.2022.878201. eCollection 2022.
10
Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.口服乳铁蛋白与硫酸亚铁补充剂治疗缺铁性贫血的效果比较:临床试验的综合评价和荟萃分析。
Nutrients. 2022 Jan 27;14(3):543. doi: 10.3390/nu14030543.